DailyIQ
|
Sector:Financial ServicesAll sectors
Last updated 1 minute ago

MET·MetLife, Inc.

$.
-. (-.%)
After Hours
High
$84.81
Open
$83.82
Market Cap
54.09B
52W High
$85.29
Low
$82.82
P. Close
$83.29
P/E
14.95
52W Low
$67.33
Fwd P/E
-
Mean Target
$91.69
Technical Score (1D)
86
BUY
News Sentiment
59
BULLISH
MET faces scrutiny today as an analysis highlights three specific risk factors, prompting consideration of alternative investments. Investors are advised to closely monitor these identified risks, which suggest potential downsides for the stock. This focus on potential headwinds is the primary driver of current market sentiment.
Earnings Summary
MetLife, Inc. is a global financial services provider specializing in insurance, annuities, employee benefits, and asset management, operating within the Financial Services sector's Insurance - Life industry. The company offers a wide array of products and services to a diverse international clientele through its six primary operating segments. Recent quarterly performance shows a mixed trend; Q1 2026 saw EPS of $2.42, beating estimates, while revenue of $19.68 billion slightly exceeded estimates of $19.42 billion. This follows a pattern where Q4 2025 EPS of $2.58 beat estimates, but revenue of $24.19 billion missed estimates of $28.00 billion. Looking at the prior two quarters, Q3 2025 EPS of $2.37 beat estimates, and Q2 2025 EPS of $2.02 missed estimates. Historically, MetLife has demonstrated a pattern of beating analyst EPS estimates in three of the last four reported quarters (Q4 2025, Q3 2025, Q1 2026, and Q4 2024), with Q1 2026 being a notable beat. Revenue figures, where available, have shown variability, with Q1 2026 revenue exceeding estimates and Q4 2025 revenue missing. Recent news highlights a mixed Q1 2026 performance with EPS beating but sales missing projections, alongside a significant miss in book value per share. However, premiums, fees, and other income saw a 5% year-over-year increase, and adjusted revenues grew by 10%. Concerns exist regarding a regulatory investigation in Japan and a potential financial impact from a class action lawsuit settlement. On a positive note, the company approved a 4.4% increase in its quarterly dividend. Forward-looking watch points for investors include monitoring revenue generation strategies in light of recent sales underperformance, the impact of regulatory and legal developments, and the continued strength of premiums, fees, and other income, as well as investment income trends.

EPS

EstBeatMiss
$1.87$2.07$2.27$2.47$2.67Q1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$2.27$2.42+6.6%
Q4'25$2.37$2.58+9.1%
Q3'25$2.32$2.37+2.2%
Q2'25$2.16$2.02-6.7%
Q1'25$2.01$1.96-2.5%

Revenue

EstBeatMiss
$16.4B$19.7B$23.0B$26.2B$29.5BQ1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$19.4B$19.7B+1.3%
Q4'25$28.0B$24.2B-13.6%
Q3'25 - $17.9B -
Q2'25 - $17.9B -
Q1'25 - $18.8B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

MET Stock Snapshot

MET is currently trading at $83.50, giving MetLife, Inc. a market cap of 54.09B and a P/E ratio of 14.9. Today's range spans $82.82–$84.81, with shares opening at $83.82 and moving up $0.21 (0.3%) from the prior close. DailyIQ's technical score sits at 86/100 (BUY) with a news sentiment reading of 59/100.

Over the past year MET has traded between $67.33 and $85.29 - the current price is +24.0% off the 52-week low and -2.1% from the high. 24 analysts cover the stock with a Buy consensus and a mean 12-month target of $91.69 (range $75.00–$106.00), implying upside of +9.8%.

In the Financial Services peer group, MetLife, Inc. (MET) stands out for a BUY signal backed by aligned sentiment - score 86/100, sentiment neutral at 59/100, price $83.50 (near 52-week highs). (P/E: 14.9) With 54.09B in market cap, this is large enough to feature on institutional watch lists but small enough to re-rate meaningfully on a positive earnings surprise. The 52-week span of $67.33–$85.29 shows the stock has already proven it can make significant moves.

Earnings revision cycles in large-cap Financial Services names tend to compound: when technicals confirm a BUY thesis (86/100) and news sentiment (59/100, neutral) supports the narrative, analyst upgrades follow price rather than lead it. At $83.50 (near 52-week highs), MET's position within the $67.33–$85.29 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.